BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 29515000)

  • 1. Exploiting an Asp-Glu "switch" in glycogen synthase kinase 3 to design paralog-selective inhibitors for use in acute myeloid leukemia.
    Wagner FF; Benajiba L; Campbell AJ; Weïwer M; Sacher JR; Gale JP; Ross L; Puissant A; Alexe G; Conway A; Back M; Pikman Y; Galinsky I; DeAngelo DJ; Stone RM; Kaya T; Shi X; Robers MB; Machleidt T; Wilkinson J; Hermine O; Kung A; Stein AJ; Lakshminarasimhan D; Hemann MT; Scolnick E; Zhang YL; Pan JQ; Stegmaier K; Holson EB
    Sci Transl Med; 2018 Mar; 10(431):. PubMed ID: 29515000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elucidation of the GSK3α Structure Informs the Design of Novel, Paralog-Selective Inhibitors.
    Amaral B; Capacci A; Anderson T; Tezer C; Bajrami B; Lulla M; Lucas B; Chodaparambil JV; Marcotte D; Kumar PR; Murugan P; Spilker K; Cullivan M; Wang T; Peterson AC; Enyedy I; Ma B; Chen T; Yousaf Z; Calhoun M; Golonzhka O; Dillon GM; Koirala S
    ACS Chem Neurosci; 2023 Mar; 14(6):1080-1094. PubMed ID: 36812145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Glycogen Synthase Kinase-3 Inhibitor Optimized for Acute Myeloid Leukemia Differentiation Activity.
    Hu S; Ueda M; Stetson L; Ignatz-Hoover J; Moreton S; Chakrabarti A; Xia Z; Karan G; de Lima M; Agrawal MK; Wald DN
    Mol Cancer Ther; 2016 Jul; 15(7):1485-1494. PubMed ID: 27196775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Off-target based drug repurposing opportunities for tivantinib in acute myeloid leukemia.
    Kuenzi BM; Remsing Rix LL; Kinose F; Kroeger JL; Lancet JE; Padron E; Rix U
    Sci Rep; 2019 Jan; 9(1):606. PubMed ID: 30679640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GSK3α: An Important Paralog in Neurodegenerative Disorders and Cancer.
    Silva-García O; Cortés-Vieyra R; Mendoza-Ambrosio FN; Ramírez-Galicia G; Baizabal-Aguirre VM
    Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33339170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycogen synthase kinase 3 alpha and 3 beta have distinct functions during cardiogenesis of zebrafish embryo.
    Lee HC; Tsai JN; Liao PY; Tsai WY; Lin KY; Chuang CC; Sun CK; Chang WC; Tsai HJ
    BMC Dev Biol; 2007 Aug; 7():93. PubMed ID: 17683539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Glycogen Synthase Kinase Inhibitors That Regulate Cytochrome P450 Expression in Primary Human Hepatocytes by Activation of β-Catenin, Aryl Hydrocarbon Receptor and Pregnane X Receptor Signaling.
    Briolotti P; Chaloin L; Balaguer P; Da Silva F; Tománková V; Pascussi JM; Duret C; Fabre JM; Ramos J; Klieber S; Maurel P; Daujat-Chavanieu M; Gerbal-Chaloin S
    Toxicol Sci; 2015 Nov; 148(1):261-75. PubMed ID: 26259606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GSK3β isoform-selective regulation of depression, memory and hippocampal cell proliferation.
    Pardo M; Abrial E; Jope RS; Beurel E
    Genes Brain Behav; 2016 Mar; 15(3):348-55. PubMed ID: 26749572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Improved Glycogen Synthase Kinase-3α Inhibitors in Models of Acute Myeloid Leukemia.
    Neumann T; Benajiba L; Göring S; Stegmaier K; Schmidt B
    J Med Chem; 2015 Nov; 58(22):8907-19. PubMed ID: 26496242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycogen synthase kinase 3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysis.
    Sugden PH; Fuller SJ; Weiss SC; Clerk A
    Br J Pharmacol; 2008 Mar; 153 Suppl 1(Suppl 1):S137-53. PubMed ID: 18204489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cellular assay for measuring the inhibition of glycogen synthase kinase-3 via the accumulation of beta-catenin in Chinese hamster ovary clone K1 cells.
    Yeow K; Novo-Perez L; Gaillard P; Page P; Gotteland JP; Scheer A; Lang P
    Assay Drug Dev Technol; 2006 Aug; 4(4):451-60. PubMed ID: 16945017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of novel glycogen synthase kinase-3α inhibitors: Structure-based virtual screening, preliminary SAR and biological evaluation for treatment of acute myeloid leukemia.
    Wang Y; Dou X; Jiang L; Jin H; Zhang L; Zhang L; Liu Z
    Eur J Med Chem; 2019 Jun; 171():221-234. PubMed ID: 30925338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor-α induces increased lung vascular permeability: a role for GSK3α/β.
    Barton-Pai A; Feleder C; Johnson A
    Eur J Pharmacol; 2011 Apr; 657(1-3):159-66. PubMed ID: 21316358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors of Glycogen Synthase Kinase 3 with Exquisite Kinome-Wide Selectivity and Their Functional Effects.
    Wagner FF; Bishop JA; Gale JP; Shi X; Walk M; Ketterman J; Patnaik D; Barker D; Walpita D; Campbell AJ; Nguyen S; Lewis M; Ross L; Weïwer M; An WF; Germain AR; Nag PP; Metkar S; Kaya T; Dandapani S; Olson DE; Barbe AL; Lazzaro F; Sacher JR; Cheah JH; Fei D; Perez J; Munoz B; Palmer M; Stegmaier K; Schreiber SL; Scolnick E; Zhang YL; Haggarty SJ; Holson EB; Pan JQ
    ACS Chem Biol; 2016 Jul; 11(7):1952-63. PubMed ID: 27128528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoform-specific requirement for GSK3α in sperm for male fertility.
    Bhattacharjee R; Goswami S; Dey S; Gangoda M; Brothag C; Eisa A; Woodgett J; Phiel C; Kline D; Vijayaraghavan S
    Biol Reprod; 2018 Aug; 99(2):384-394. PubMed ID: 29385396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in the Therapeutic Potential of Inhibitors Targeting Glycogen Synthase Kinase 3 in Inflammatory Diseases.
    Zhu Y; Wang H; Guo Y; Cao J; Li H
    Mini Rev Med Chem; 2023; 23(19):1893-1904. PubMed ID: 37055897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FBW7 Inhibits Myeloid Differentiation in Acute Myeloid Leukemia via GSK3-Dependent Ubiquitination of PU.1.
    Mishra M; Thacker G; Sharma A; Singh AK; Upadhyay V; Sanyal S; Verma SP; Tripathi AK; Bhatt MLB; Trivedi AK
    Mol Cancer Res; 2021 Feb; 19(2):261-273. PubMed ID: 33188146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GSK3alpha exhibits beta-catenin and tau directed kinase activities that are modulated by Wnt.
    Asuni AA; Hooper C; Reynolds CH; Lovestone S; Anderton BH; Killick R
    Eur J Neurosci; 2006 Dec; 24(12):3387-92. PubMed ID: 17229088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GSK-3 as a novel prognostic indicator in leukemia.
    Ruvolo PP
    Adv Biol Regul; 2017 Aug; 65():26-35. PubMed ID: 28499784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of glycogen synthase kinase 3 alpha and calcineurin in regulating the ability of sperm to fertilize eggs.
    Dey S; Eisa A; Kline D; Wagner FF; Abeysirigunawardena S; Vijayaraghavan S
    FASEB J; 2020 Jan; 34(1):1247-1269. PubMed ID: 31914663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.